Literature DB >> 10611106

Sponge delivery variables and tissue levels of 5-fluorouracil.

M R Wilkins1, N L Occleston, A Kotecha, L Waters, P T Khaw.   

Abstract

AIM: To study how the delivery of 5-fluorouracil (5-FU) to ocular tissues is affected by altering delivery variables.
METHOD: Sponge(s) soaked in radiolabelled 5-FU were placed between the conjunctiva and sclera of pig eyes. Application time, sponge size, sponge make (Altomed, Weck, Merocel), and 5-FU concentration were varied. Conjunctival and scleral tissue levels were determined in samples taken from the application site.
RESULTS: Dose-response curves for scleral and conjunctival 5-FU levels against application time showed increasing tissue levels that reached a plateau after 2-3 minutes. Application beyond 3 minutes did not increase tissue levels. There was no difference in tissue levels between 7x4 and 3. 5x2 mm sponges. Altomed sponges produced 5-FU tissue levels that were twice as high as those obtained with Weck-cell (p<0.01) or Merocel (p<0.02) sponges. Changing the 5-FU concentration from 25 mg/ml to 6.25 mg/ml reduced the conjunctival concentration by a factor of 3.5 (p<0.003).
CONCLUSION: Application time up to 3 minutes, sponge make, and 5-FU concentration can have a large effect on the tissue delivery of 5-FU. Application time beyond 3 minutes, using 3.5x2 mm or 7x4 mm sponges, and replacing sponges every minute did not have a significant effect on tissue levels. This study models the effect that different variables can have on the ocular tissue levels of an antimetabolite applied intraoperatively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10611106      PMCID: PMC1723231          DOI: 10.1136/bjo.84.1.92

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  38 in total

1.  Endophthalmitis after filtering surgery with mitomycin.

Authors:  D S Greenfield; I J Suñer; M P Miller; T A Kangas; P F Palmberg; H W Flynn
Journal:  Arch Ophthalmol       Date:  1996-08

2.  Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma.

Authors:  V P Costa; P E Comegno; J P Vasconcelos; R F Malta; N K José
Journal:  J Glaucoma       Date:  1996-06       Impact factor: 2.503

3.  Needle elevation of the scleral flap for failing filtration blebs after trabeculectomy with mitomycin C.

Authors:  D S Greenfield; M P Miller; I J Suner; P F Palmberg
Journal:  Am J Ophthalmol       Date:  1996-08       Impact factor: 5.258

4.  A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures.

Authors:  J S Cohen; L J Greff; G D Novack; B E Wind
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

5.  Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure.

Authors:  D H Shin; B A Hughes; M S Song; C Kim; K J Yang; M I Shah; M S Juzych; T Obertynski
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

Review 6.  Trabeculectomy with intraoperative sponge 5-fluorouracil.

Authors:  J S Mora; N Nguyen; A G Iwach; M M Gaffney; J Hetherington; H D Hoskins; P C Wong; H Tran; C J Dickens
Journal:  Ophthalmology       Date:  1996-06       Impact factor: 12.079

7.  Combined cataract extraction with intraocular lens implant and mitomycin-augmented trabeculectomy.

Authors:  C M Lederer
Journal:  Ophthalmology       Date:  1996-07       Impact factor: 12.079

8.  Short-term clinical results and complications of trabeculectomies performed with mitomycin C using different concentrations.

Authors:  H Mietz; G K Krieglstein
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

9.  Bleb-related endophthalmitis after trabeculectomy with mitomycin C.

Authors:  E J Higginbotham; R K Stevens; D C Musch; K O Karp; P R Lichter; T J Bergstrom; G L Skuta
Journal:  Ophthalmology       Date:  1996-04       Impact factor: 12.079

10.  Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment.

Authors:  E B Dreyer; N Chaturvedi; D Zurakowski
Journal:  Arch Ophthalmol       Date:  1995-05
View more
  6 in total

1.  Standardization of the dose of intraoperative mitomycin C in trabeculectomy.

Authors:  G Krommes; W Lieb; F Grehn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-07       Impact factor: 3.117

2.  Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure.

Authors:  R Casson; R Rahman; J F Salmon
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

3.  The moorfields safer surgery system.

Authors:  Sumit Dhingra; Peng T Khaw
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

4.  National survey of antimetabolite use in glaucoma surgery in the United Kingdom.

Authors:  D Siriwardena; B Edmunds; R P L Wormald; P T Khaw
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

5.  Comparison of ophthalmic sponges and extraction buffers for quantifying cytokine profiles in tears using Luminex technology.

Authors:  Aleksandra Inic-Kanada; Andrea Nussbaumer; Jacqueline Montanaro; Sandra Belij; Simone Schlacher; Elisabeth Stein; Nora Bintner; Margarethe Merio; Gerhard J Zlabinger; Talin Barisani-Asenbauer
Journal:  Mol Vis       Date:  2012-11-16       Impact factor: 2.367

6.  Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study.

Authors:  Juan F Batlle; Adalgisa Corona; Rachel Albuquerque
Journal:  J Glaucoma       Date:  2021-03-01       Impact factor: 2.290

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.